{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04765137",
            "orgStudyIdInfo": {
                "id": "IRB00256402"
            },
            "organization": {
                "fullName": "Johns Hopkins University",
                "class": "OTHER"
            },
            "briefTitle": "Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)",
            "officialTitle": "Targeting Cerebrovascular Reactivity for Precision Medicine: Pilot Trial of Atorvastatin",
            "therapeuticArea": [
                "Other"
            ],
            "study": "evaluate-the-effect-of-atorvastatin-on-cerebrovascular-reactivity-in-mild-cognitive-impairment-mci"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-05-21",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-02-18",
            "studyFirstSubmitQcDate": "2021-02-18",
            "studyFirstPostDateStruct": {
                "date": "2021-02-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Johns Hopkins University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "The Richman Family Precision Medicine Center of Excellence in Alzheimer Disease",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the effect of atorvastatin on brain vessel reactivity and with it on blood flow in people with mild cognitive impairment.",
            "detailedDescription": "Participants are first being informed about potential benefits and risks of the study and are required to give written consent. After that participants will undergo detailed phone screen to determine eligibility for study entry. At week 0, participants who meet eligibility requirements will be prescribed atorvastatin (40 mg, once in the evening) in an open-label manner."
        },
        "conditionsModule": {
            "conditions": [
                "Mild Cognitive Impairment"
            ],
            "keywords": [
                "Cerebral Vascular Reactivity"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "Open-label study with atorvastatin 40 mg",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Atorvastatin 40 mg",
                    "type": "EXPERIMENTAL",
                    "description": "Participants receive 40 mg atorvastatin orally daily in the evening.",
                    "interventionNames": [
                        "Drug: Atorvastatin Oral Tablet"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Atorvastatin Oral Tablet",
                    "description": "Atorvastatin pill 40 mg to be taken every night",
                    "armGroupLabels": [
                        "Atorvastatin 40 mg"
                    ],
                    "otherNames": [
                        "Lipitor oral tablet"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change of MRI whole brain cerebrovascular reactivity (wbCVR)",
                    "description": "MRI based CVR is a newer technique that measures dilatory function of the microvessels which have been shown to be superior to measurement of Cerebral blood flow (CBF) and have also been shown to be low in participants with MCI.",
                    "timeFrame": "Baseline and 12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in plasma exosomes",
                    "description": "Endothelial-derived exosomes (EDE) reflect the neurochemistry of cerebrovascular endothelial cells, while neuronal-enriched extracellular vesicles (nEV) are associated with brain white matter hyperintensities.",
                    "timeFrame": "Baseline and 12 weeks"
                },
                {
                    "measure": "Change in cognitive function (global neurocognitive measure)",
                    "description": "Assessed by Global neurocognitive measure.",
                    "timeFrame": "Baseline and 12 weeks"
                },
                {
                    "measure": "Change in cognitive function (domain-specific neurocognitive measure)",
                    "description": "Assessed by Domain-specific neurocognitive measure.",
                    "timeFrame": "Baseline and 12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria are chosen to include participants with MCI, enriched for vascular risk factors:\n\n* MCI defined by Clinical Dementia Rating (CDR) of 0.5 or 1.0.\n* Memory, processing speed, executive function, language - cognitive scores \\> 1.5 standard deviations below age-education norms.\n* Not demented by history.\n* Not taking statins currently or in the last 6 months.\n* Cognitive/functional impairment not likely due to another neurological disease or delirium.\n\nExclusion Criteria:\n\n* Taking a statin currently or have taken a statin in the last 6 months.\n* Contraindications to taking a statin.\n* Transplant patient taking cyclosporine.\n* Unable to undergo MRI procedures (such as having an implanted pacemaker or defibrillator or stimulator or having non MRI compatible metal).\n* Diagnosis of dementia by history.\n* Current diagnosis of substance abuse.\n* History of stroke or myocardial infarction in past 6 months.\n* History of HIV.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "60 Years",
            "maximumAge": "95 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Samantha Horn",
                    "role": "CONTACT",
                    "phone": "410-550-9020",
                    "email": "shorn8@jhmi.edu"
                },
                {
                    "name": "Ritu Agarwal",
                    "role": "CONTACT",
                    "phone": "410-550-9020",
                    "email": "ragarw19@jhmi.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Paul Rosenberg, MD",
                    "affiliation": "Johns Hopkins University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Johns Hopkins University, Bayview Medical Center",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Samantha Horn",
                            "role": "CONTACT",
                            "phone": "410-550-9020",
                            "email": "shorn8@jhmi.edu"
                        },
                        {
                            "name": "Ritu Agarwal",
                            "role": "CONTACT",
                            "phone": "410-550-9020",
                            "email": "ragarw19@jhmi.edu"
                        },
                        {
                            "name": "Paul Rosenberg, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Sevil Yasar, MD, PhD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000060825",
                    "term": "Cognitive Dysfunction"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003072",
                    "term": "Cognition Disorders"
                },
                {
                    "id": "D000019965",
                    "term": "Neurocognitive Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M29705",
                    "name": "Cognitive Dysfunction",
                    "asFound": "Mild Cognitive Impairment",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6301",
                    "name": "Cognition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21836",
                    "name": "Neurocognitive Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069059",
                    "term": "Atorvastatin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000924",
                    "term": "Anticholesteremic Agents"
                },
                {
                    "id": "D000000960",
                    "term": "Hypolipidemic Agents"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000057847",
                    "term": "Lipid Regulating Agents"
                },
                {
                    "id": "D000019161",
                    "term": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M351",
                    "name": "Atorvastatin",
                    "asFound": "Out",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4243",
                    "name": "Anticholesteremic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4278",
                    "name": "Hypolipidemic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M28883",
                    "name": "Lipid Regulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21155",
                    "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Lipd",
                    "name": "Lipid Regulating Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}